These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8657719)

  • 1. The use of archival frozen tumor tissue imprint specimens for fluorescence in situ hybridization.
    Demetrick DJ
    Mod Pathol; 1996 Feb; 9(2):133-6. PubMed ID: 8657719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
    Bozzetti C; Personeni N; Nizzoli R; Guazzi A; Flora M; Bassano C; Negri F; Martella E; Naldi N; Franciosi V; Cascinu S
    Cancer; 2003 Oct; 99(5):310-5. PubMed ID: 14579298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F; Shen T; Prichard JW
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer.
    Heselmeyer-Haddad K; Chaudhri N; Stoltzfus P; Cheng JC; Wilber K; Morrison L; Auer G; Ried T
    Cancer Res; 2002 Apr; 62(8):2365-9. PubMed ID: 11956098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing HER-2 status in fresh frozen and archival cytological samples obtained by fine needle aspiration cytology.
    Tomás AR; Praça MJ; Fonseca R; André S; Mendonça E
    Cytopathology; 2004 Dec; 15(6):311-4. PubMed ID: 15606363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
    Bentz JS; Rowe LR; Anderson SR; Gupta PK; McGrath CM
    Cancer; 2004 Apr; 102(2):124-31. PubMed ID: 15098257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
    Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
    Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.
    Zhao J; Wu R; Au A; Marquez A; Yu Y; Shi Z
    Mod Pathol; 2002 Jun; 15(6):657-65. PubMed ID: 12065780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers: three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals.
    Itoh H; Miyajima Y; Umemura S; Osamura RY
    Cancer; 2008 Apr; 114(2):134-40. PubMed ID: 18306351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens.
    Shousha S; Peston D; Amo-Takyi B; Morgan M; Jasani B
    Histopathology; 2009 Jan; 54(2):248-53. PubMed ID: 19207950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
    Persons DL; Borelli KA; Hsu PH
    Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue microarrays for gene amplification surveys in many different tumor types.
    Schraml P; Kononen J; Bubendorf L; Moch H; Bissig H; Nocito A; Mihatsch MJ; Kallioniemi OP; Sauter G
    Clin Cancer Res; 1999 Aug; 5(8):1966-75. PubMed ID: 10473073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential value of comparative genomic hybridization analysis in effusion-and fine needle aspiration cytology.
    Nagel H; Schulten HJ; Gunawan B; Brinck U; Füzesi L
    Mod Pathol; 2002 Aug; 15(8):818-25. PubMed ID: 12181266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?
    Bhargava R; Lal P; Chen B
    Am J Clin Pathol; 2005 Feb; 123(2):237-43. PubMed ID: 15842048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
    Adduci KM; Annis CE; DeVries S; Chew KL; Boutin J; Magrane G; Ljung BM; Waldman FM; Esserman LJ
    Cancer; 2007 Jun; 111(3):185-91. PubMed ID: 17474121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours.
    Laakso M; Tanner M; Isola J
    J Pathol; 2006 Sep; 210(1):3-9. PubMed ID: 16823892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
    Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
    Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.